Efficacy and Safety of Intrathecal Administration of Thiotepa in Combination With Trastuzumab in Breast Cancer With Leptomeningeal Metastasis
Clinical trial NCT07263425 · RECRUITING
Trial details
- NCT number
- NCT07263425
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-27
- Primary completion
- 2027-10-27
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.